Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 371-380 of 525 for center for individualized medicine

Edit search filters
  1. DNA (cfDNA) Blood Test to Detect KRAS and Other Clinically Relevant Gene Mutations in Patients with Metastatic Colorectal Cancer

    Rochester, MN

  2. A Study of an Integrated Approach to Treating Recurrent Lung Adenocarcinomas Resistant to Tyrosine Kinase Inhibitors

    Rochester, MN

  3. Plasma Proneurotensin as a Predictive Biomarker for Breast Cancer in Genetically Predisposed Patients

    Rochester, MN

  4. Electrogram-Guided Myocardial Advanced Phenotyping (The eMAP Trial)

    Rochester, MN

  5. Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Detection of Microorganisms and Antibiotic Resistance Genes Using the Curetis UnyveroTM LRT55 Application

    Rochester, MN

  7. Epilepsy Genetics Initiative (EGI)

    Rochester, MN

  8. Diagnostic and Prognostic Validity of Tissue-based Biomarker Assay for Acute Graft-versus-host Disease of the Skin: A Retrospective Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study of Genes that cause Cystic Kidney Disease

    Rochester, MN

  10. Treatment of Multifocal Lung Adenocarcinoma

    Rochester, MN

.

Mayo Clinic Footer